Palliative Care Unit, Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Acta Paediatr. 2021 May;110(5):1673-1681. doi: 10.1111/apa.15713. Epub 2021 Feb 9.
To compare indicators of high-intensity treatment at end-of-life (HI-EOL) among children according to causes of death.
We conducted a nationwide registry study in Denmark among 938 children of 1-17 years of age who died from natural causes from 2006 to 2016. We identified and compared indicators of HI-EOL within the last month of life across diagnoses. Indicators were hospital admissions, days in hospital, intensive care unit admission, mechanical ventilation, and hospital death.
Proportions of each indicator of HI-EOL ranged from 27% to 75%. The most common indicators were hospital death (75%) and ICU admission (39%). Compared to children with solid tumours, children with non-cancerous conditions had an adjusted odds ratio of 3.5 (95% CI 2.1-5.9) of having ≥3 indicators of HI-EOL within the last month of life and children with haematological cancer had an odds ratio of 11.8 (95% CI 6.1-23.0).
The underlying diagnosis was strongly associated with HI-EOL. Children who died from solid tumours experienced substantially less intensive treatment than both children with haematological cancer and non-cancerous conditions did. Across non-cancerous diagnoses, the intensity of treatment appeared consistent, which may indicate, that the awareness of palliative care is higher among oncologists than within other paediatric fields.
根据死因比较终末高强度治疗(HI-EOL)的指标在儿童中的差异。
我们在丹麦进行了一项全国性的注册研究,纳入了 2006 年至 2016 年间因自然原因死亡的 938 名 1-17 岁儿童。我们在生命的最后一个月内,根据诊断识别和比较 HI-EOL 的指标。指标包括住院、住院天数、重症监护病房入院、机械通气和医院死亡。
HI-EOL 各项指标的比例为 27%-75%。最常见的指标是医院死亡(75%)和 ICU 入院(39%)。与患有实体瘤的儿童相比,患有非癌症疾病的儿童在生命的最后一个月内有≥3 项 HI-EOL 指标的调整优势比为 3.5(95%可信区间 2.1-5.9),患有血液癌的儿童优势比为 11.8(95%可信区间 6.1-23.0)。
基础诊断与 HI-EOL 密切相关。死于实体瘤的儿童经历的高强度治疗明显少于血液癌和非癌症疾病的儿童。在非癌症诊断中,治疗强度似乎一致,这可能表明肿瘤学家对姑息治疗的认识高于其他儿科领域。